Brief: Inventiva End-Dec Cash Position At EUR 113.0 Mln

Inventiva SA

05/03/2021 07:19

March 5 (Reuters) - INVENTIVA SA  IVAA.PA :
    * ANNOUNCED ON THURSDAY ITS FY RESULTS
    * FY REVENUES EUR 0.4 MLN VS EUR 7.0 MLN YR AGO
    * FY OTHER INCOME EUR 4.9 MLN VS EUR 4.3 MLN YR AGO
    * NET LOSS FOR THE PERIOD EUR 33.6 MILLION VS LOSS EUR 30.2
MILLION YR AGO
    * CASH POSITION AT EUR 113.0 MLN AS OF DECEMBER 31, 2020
COMPARED
TO EUR 35.8 MLN AS OF DECEMBER 31, 2019
    * SUCCESSFUL EUR 94.9M INITIAL PUBLIC OFFERING (IPO) ON
NASDAQ
GLOBAL MARKET IN U.S, EXTENDING GROUP'S CASH RUNWAY THROUGH Q4
2022
    * PHASE II CLINICAL TRIAL WITH LANIFIBRANOR IN TYPE 2
DIABETES
PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE: STUDY RESULTS
ARE NOW EXPECTED IN H1 OF 2022, DUE TO COVID-19
    * DUE TO COVID-19, CEDIROGANT PHASE I CLINICAL STUDY IN
PSORIASIS
PATIENTS LED BY ABBVIE IS NOW EXPECTED TO READ OUT IN Q2 2021

    
 Source text for Eikon:  ID:nGNE8ZdvfN 
 Further company coverage:  IVAA.PA  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))